Simmons Bank’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.2M | Sell |
36,219
-3,945
| -10% | -$230K | 0.15% | 140 |
|
|
2025
Q4 | $2.17M | Sell |
40,164
-3,431
| -8% | -$165K | 0.14% | 142 |
|
|
2025
Q3 | $1.97M | Sell |
43,595
-1,714
| -4% | -$80K | 0.13% | 144 |
|
|
2025
Q2 | $2.1M | Buy |
45,309
+2,317
| +5% | +$114K | 0.15% | 137 |
|
|
2025
Q1 | $2.62M | Buy |
42,992
+4,236
| +11% | +$247K | 0.2% | 115 |
|
|
2024
Q4 | $2.19M | Sell |
38,756
-720
| -2% | -$40.2K | 0.16% | 132 |
|
|
2024
Q3 | $2.04M | Sell |
39,476
-4,791
| -11% | -$225K | 0.15% | 133 |
|
|
2024
Q2 | $1.84M | Sell |
44,267
-1,225
| -3% | -$54.8K | 0.14% | 138 |
|
|
2024
Q1 | $2.47M | Sell |
45,492
-214
| -0.5% | -$10.9K | 0.19% | 119 |
|
|
2023
Q4 | $2.35M | Sell |
45,706
-4,455
| -9% | -$234K | 0.19% | 119 |
|
|
2023
Q3 | $2.91M | Sell |
50,161
-1,660
| -3% | -$102K | 0.26% | 95 |
|
|
2023
Q2 | $3.31M | Sell |
51,821
-1,152
| -2% | -$77.2K | 0.28% | 91 |
|
|
2023
Q1 | $3.67M | Sell |
52,973
-1,998
| -4% | -$141K | 0.31% | 88 |
|
|
2022
Q4 | $3.96M | Sell |
54,971
-1,746
| -3% | -$132K | 0.34% | 79 |
|
|
2022
Q3 | $4.03M | Sell |
56,717
-2,799
| -5% | -$203K | 0.38% | 71 |
|
|
2022
Q2 | $4.58M | Sell |
59,516
-1,354
| -2% | -$103K | 0.4% | 67 |
|
|
2022
Q1 | $4.45M | Sell |
60,870
-9,437
| -13% | -$634K | 0.33% | 77 |
|
|
2021
Q4 | $4.38M | Sell |
70,307
-4,162
| -6% | -$244K | 0.31% | 80 |
|
|
2021
Q3 | $4.41M | Sell |
74,469
-1,166
| -2% | -$76.8K | 0.32% | 78 |
|
|
2021
Q2 | $5.05M | Sell |
75,635
-5,271
| -7% | -$344K | 0.37% | 72 |
|
|
2021
Q1 | $5.11M | Sell |
80,906
-4,959
| -6% | -$309K | 0.39% | 66 |
|
|
2020
Q4 | $5.33M | Sell |
85,865
-4,343
| -5% | -$267K | 0.42% | 62 |
|
|
2020
Q3 | $5.44M | Sell |
90,208
-1,656
| -2% | -$99.7K | 0.45% | 56 |
|
|
2020
Q2 | $5.4M | Sell |
91,864
-117
| -0.1% | -$7K | 0.45% | 55 |
|
|
2020
Q1 | $5.13M | Buy |
91,981
+4,823
| +6% | +$295K | 0.45% | 53 |
|
|
2019
Q4 | $5.59M | Buy |
87,158
+14,977
| +21% | +$858K | 0.5% | 48 |
|
|
2019
Q3 | $3.66M | Buy |
72,181
+45,215
| +168% | +$2.13M | 0.36% | 65 |
|
|
2019
Q2 | $1.22M | Sell |
26,966
-1,518
| -5% | -$70.7K | 0.12% | 155 |
|
|
2019
Q1 | $1.36M | Sell |
28,484
-1,858
| -6% | -$92.6K | 0.13% | 150 |
|
|
2018
Q4 | $1.58M | Sell |
30,342
-910
| -3% | -$48.9K | 0.18% | 117 |
|
|
2018
Q3 | $1.94M | Sell |
31,252
-119
| -0.4% | -$7.06K | 0.19% | 115 |
|
|
2018
Q2 | $1.74M | Buy |
31,371
+477
| +2% | +$25.8K | 0.16% | 124 |
|
|
2018
Q1 | $3.51M | Buy |
30,894
+6,457
| +26% | +$415K | 0.32% | 59 |
|
|
2017
Q4 | $1.5M | Sell |
24,437
-1,235
| -5% | -$77.2K | 0.15% | 121 |
|
|
2017
Q3 | $1.64M | Buy |
25,672
+2,350
| +10% | +$137K | 0.17% | 119 |
|
|
2017
Q2 | $1.3M | Sell |
23,322
-17,412
| -43% | -$947K | 0.15% | 130 |
|
|
2017
Q1 | $2.21M | Buy |
40,734
+17,556
| +76% | +$963K | 0.24% | 79 |
|
|
2016
Q4 | $1.35M | Buy |
23,178
+1,198
| +5% | +$65.5K | 0.15% | 128 |
|
|
2016
Q3 | $1.19M | Buy |
21,980
+445
| +2% | +$28.6K | 0.13% | 137 |
|
|
2016
Q2 | $1.58M | Sell |
21,535
-891
| -4% | -$63K | 0.18% | 113 |
|
|
2016
Q1 | $1.43M | Buy |
+22,426
| New | +$1.41M | 0.16% | 128 |
|
Other funds holding BMY
VCM
VPM
Simmons Bank's BMY Position: Q1 2026 in Review
Simmons Bank reduced its Bristol-Myers Squibb (BMY) stake by 9.8% in Q1 2026, selling an estimated $230K and leaving 36,219 shares worth $2.2M. The position accounts for 0.15% of the portfolio, ranked #140.
Simmons Bank first reported a position in BMY in Q1 2016 and has held it in 41 quarters since. The position peaked at $5.59M in Q4 2019. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Simmons Bank held 36,219 shares of Bristol-Myers Squibb worth $2.2M as of Q1 2026.
- Simmons Bank sold 3,945 Bristol-Myers Squibb shares in Q1 2026, an estimated $230K.
- Bristol-Myers Squibb made up 0.15% of Simmons Bank's portfolio in Q1 2026, its #140 holding.
- Simmons Bank first reported a position in Bristol-Myers Squibb in Q1 2016 and has held it in 41 quarters since.
- Simmons Bank's Bristol-Myers Squibb position peaked at $5.59M in Q4 2019.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Simmons Bank's 13F filing for Q1 2026, filed 23 Apr 2026.